WrapManager Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $407K | Sell |
820
-23
| -3% | -$10.2K | 0.13% | 103 |
|
|
2026
Q1 | $376K | Sell |
843
-313
| -27% | -$146K | 0.13% | 102 |
|
|
2025
Q4 | $524K | Sell |
1,156
-23
| -2% | -$9.91K | 0.18% | 91 |
|
|
2025
Q3 | $462K | Sell |
1,179
-595
| -34% | -$249K | 0.14% | 103 |
|
|
2025
Q2 | $790K | Sell |
1,774
-69
| -4% | -$31.8K | 0.19% | 93 |
|
|
2025
Q1 | $894K | Sell |
1,843
-205
| -10% | -$95.5K | 0.23% | 82 |
|
|
2024
Q4 | $825K | Sell |
2,048
-245
| -11% | -$114K | 0.21% | 86 |
|
|
2024
Q3 | $1.07M | Sell |
2,293
-512
| -18% | -$246K | 0.28% | 76 |
|
|
2024
Q2 | $1.31M | Sell |
2,805
-760
| -21% | -$330K | 0.36% | 65 |
|
|
2024
Q1 | $1.49M | Sell |
3,565
-520
| -13% | -$220K | 0.41% | 62 |
|
|
2023
Q4 | $1.66M | Sell |
4,085
-341
| -8% | -$126K | 0.49% | 55 |
|
|
2023
Q3 | $1.54M | Sell |
4,426
-288
| -6% | -$101K | 0.49% | 53 |
|
|
2023
Q2 | $1.66M | Sell |
4,714
-415
| -8% | -$140K | 0.51% | 51 |
|
|
2023
Q1 | $1.62M | Sell |
5,129
-116
| -2% | -$34.8K | 0.5% | 49 |
|
|
2022
Q4 | $1.51M | Sell |
5,245
-48
| -0.9% | -$14.6K | 0.49% | 52 |
|
|
2022
Q3 | $1.53M | Sell |
5,293
-1,179
| -18% | -$339K | 0.52% | 46 |
|
|
2022
Q2 | $1.82M | Sell |
6,472
-793
| -11% | -$212K | 0.57% | 43 |
|
|
2022
Q1 | $1.9M | Sell |
7,265
-857
| -11% | -$203K | 0.51% | 43 |
|
|
2021
Q4 | $1.78M | Sell |
8,122
-996
| -11% | -$194K | 0.45% | 54 |
|
|
2021
Q3 | $1.65M | Sell |
9,118
-184
| -2% | -$35.9K | 0.43% | 52 |
|
|
2021
Q2 | $1.88M | Buy |
9,302
+36
| +0.4% | +$7.53K | 0.48% | 51 |
|
|
2021
Q1 | $1.99M | Buy |
9,266
+1,771
| +24% | +$389K | 0.55% | 46 |
|
|
2020
Q4 | $1.77M | Buy |
7,495
+963
| +15% | +$221K | 0.52% | 51 |
|
|
2020
Q3 | $1.78M | Buy |
6,532
+917
| +16% | +$253K | 0.6% | 50 |
|
|
2020
Q2 | $1.63M | Sell |
5,615
-172
| -3% | -$46.6K | 0.6% | 45 |
|
|
2020
Q1 | $1.38M | Sell |
5,787
-780
| -12% | -$179K | 0.61% | 40 |
|
|
2019
Q4 | $1.44M | Sell |
6,567
-430
| -6% | -$87K | 0.45% | 54 |
|
|
2019
Q3 | $1.19M | Sell |
6,997
-228
| -3% | -$40.3K | 0.39% | 68 |
|
|
2019
Q2 | $1.32M | Buy |
7,225
+102
| +1% | +$17.8K | 0.43% | 60 |
|
|
2019
Q1 | $1.31M | Sell |
7,123
-318
| -4% | -$58.7K | 0.43% | 59 |
|
|
2018
Q4 | $1.23M | Sell |
7,441
-50
| -0.7% | -$8.66K | 0.44% | 56 |
|
|
2018
Q3 | $1.44M | Buy |
7,491
+34
| +0.5% | +$6.05K | 0.46% | 53 |
|
|
2018
Q2 | $1.27M | Sell |
7,457
-490
| -6% | -$76K | 0.42% | 68 |
|
|
2018
Q1 | $1.29M | Sell |
7,947
-85
| -1% | -$13.9K | 0.43% | 63 |
|
|
2017
Q4 | $1.2M | Sell |
8,032
-156
| -2% | -$23.1K | 0.4% | 54 |
|
|
2017
Q3 | $1.25M | Sell |
8,188
-6
| -0.1% | -$903 | 0.42% | 57 |
|
|
2017
Q2 | $1.06M | Buy |
8,194
+237
| +3% | +$28.5K | 0.37% | 71 |
|
|
2017
Q1 | $870K | Buy |
7,957
+686
| +9% | +$60.4K | 0.32% | 81 |
|
|
2016
Q4 | $536K | Sell |
7,271
-46
| -0.6% | -$3.74K | 0.21% | 107 |
|
|
2016
Q3 | $638K | Sell |
7,317
-36
| -0.5% | -$3.4K | 0.25% | 93 |
|
|
2016
Q2 | $633K | Buy |
7,353
+313
| +4% | +$27K | 0.26% | 93 |
|
|
2016
Q1 | $560K | Buy |
7,040
+514
| +8% | +$46.5K | 0.25% | 96 |
|
|
2015
Q4 | $821K | Buy |
+6,526
| New | +$788K | 0.4% | 70 |
|
Other funds holding VRTX
WrapManager Inc's VRTX Position: Q2 2026 in Review
WrapManager Inc reduced its Vertex Pharmaceuticals (VRTX) stake by 2.7% in Q2 2026, selling an estimated $10.2K and leaving 820 shares worth $407K. The position accounts for 0.13% of the portfolio, ranked #103.
WrapManager Inc first reported a position in VRTX in Q4 2015 and has held it in 43 quarters since. The position peaked at $1.99M in Q1 2021. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- WrapManager Inc held 820 shares of Vertex Pharmaceuticals worth $407K as of Q2 2026.
- WrapManager Inc sold 23 Vertex Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
- Vertex Pharmaceuticals made up 0.13% of WrapManager Inc's portfolio in Q2 2026, its #103 holding.
- WrapManager Inc first reported a position in Vertex Pharmaceuticals in Q4 2015 and has held it in 43 quarters since.
- WrapManager Inc's Vertex Pharmaceuticals position peaked at $1.99M in Q1 2021.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on WrapManager Inc's 13F filing for Q2 2026, filed 5 Aug 2026.